Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882

Radiotherapy and Oncology

Volumn 82, Issue 3, 2007, Pages 265-271

  Antonini, Ninja ^a   Jones, Heather ^b   Horiot, Jean Claude ^f   Poortmans, Philip ^h   Struikmans, Henk ⁱ   den Bogaert, Walter Van ^j   Barillot, Isabelle ^k   Fourquet, Alain ^d   Jager, Jos ^g   Hoogenraad, Willem ^e   Collette, Laurence ^c   Pierart, Marianne ^c   Hart, Guus ^a   Bartelink, Harry ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c EORTC DATA CENTER   (Belgium)

^d INSTITUT CURIE   (France)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f CENTRE GEORGES FRANÇOIS LECLERC   (France)

^g MAASTRO CLINIC   (Netherlands)

^h DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k CHU BRETONNEAU   (France)

more..

Author keywords

Age; Boost; Breast cancer; Dose effect; Local control; Treatment strategy

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DOSIMETRY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; RISK REDUCTION; TREATMENT FAILURE; TREATMENT PLANNING;

ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FLUOROURACIL; HUMANS; MASTECTOMY, SEGMENTAL; METHOTREXATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK;

EID: 33847363048     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.09.014     Document Type: Article

References (25)

1. Veronesi U., Salvadori B., Luini A., et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1973 patients. Eur J Cancer 31A (1995) 1574-1579
2. Blichert-Toft M., Rose C., Andersen J.A., et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (1992) 19-25
3. Sarrazin D., Le M.G., Arriagada R., et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14 (1989) 177-184
4. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
5. van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
6. Early Breast Cancer Trialists' Collaborative Group: Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2002;355:1757-70.
7. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 (2001) 997-1003
8. Forrest A.P., Stewart H.J., Everington D., et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348 (1996) 708-713
9. Liljegren G., Holmberg L., Bergh J., et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17 (1999) 2326-2333
10. Bartelink H. Radiotherapy to the conserved breast, chest wall, and regional nodes: is there a standard?. Breast 12 (2003) 475-482
11. Romestaing P., Lehingue Y., Carrie C., et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 15 (1997) 963-968
12. Fodor J., Mozsa E., Zaka Z., Polgar C., and Major T. Local relapse in young (≤40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results. Magy Onkol 49 (2005) 203-208 Epub 2005 Oct 25. Hungarian
13. Vrieling C., Collette L., Fourquet A., et al. Can patient-, treatment- and pathology related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer 39 (2003) 932-944
14. Bartelink H., Horiot J.C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387
15. Harrell F.E. Regression modeling strategies with application to linear models, logistic regression, and survival analysis (2001), Springer-Verlag, New York
16. Miller Jr. R.G. Simultaneous statistical inference (1981), Springer Verlag, New York
17. Bonnier P., Romain S., Charpin C., et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62 (1995) 138-144
18. De la Rochefordière A., Asselain B., Campana F., et al. Age as prognostic factor in premenopausal breast carcinoma. Lancet 341 (1993) 1039-1043
19. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
20. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
21. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
22. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005;366:2087-106.
23. Van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
24. Van't Veer L.J., Dai H., van de Vijver M.J., et al. Expression profiling predicts outcome in breast cancer. Breast Cancer Res 5 (2003) 57-58
25. Chang H.Y., Nuyten D.S., Sneddon J.B., et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102 (2005) 3738-3743